Harith Rajagopalan
Co-Founder, President, CEO, Director & Principal Executive OfficerDr. Harith Rajagopalan, MD., Ph.D. is the Co-Founder since 2010 and also serves as Chief Executive Officer and Director since 2011 at Fractyl Health, Inc. and has been its President since October 30, 2026 and served as its Secretary. He serves as Principal Executive Officer at Fractyl Health, Inc. He serves as a Medical Consultant at DC Devices, where he advises DC in its preclinical research and development activities. Dr. Rajagopalan was an Entrepreneur and Technologist-in-Residence at General Catalyst Partners from 2009 to 2011. Dr. Rajagopalan trained in internal medicine and clinical cardiology at Brigham and Women’s Hospital in Boston, Massachusetts from 2005 to 2011 and completed a research fellowship at Harvard Medical School from 2009 to 2011. Dr. Rajagopalan won the Michael A. Shanoff award for his findings in colorectal cancer genetics and published this work in top medical journals, such as Nature and Science. He holds M.D. and Ph.D. degrees from Johns Hopkins School of Medicine. Dr. Rajagopalan holds a B.S. in Chemistry from Stanford University, where he gained a passion for both biomedical research and entrepreneurship.
Positions
- Company NameFractyl Health, Inc.Stock CodeGUTSPositionCo-Founder, President, CEO, Director & Principal Executive OfficerColleagues
- AGAjay Gopal RoyanIndependent Chairman
- SSSarah S. ToomeyGeneral Counsel & Corporate Secretary
- LSLara Smith WeberCFO & Treasurer
- BLBrian LuqueHead of Investor Relations & Corporate Development
- JFJon FitzgeraldSenior Vice President of Regulatory, Quality & Clinical
- WWWilliam Warren BradleyIndependent Director
- CAClive A. MeanwellIndependent Director
- KBKelly BarnesIndependent Director
